The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Mouth Neoplasms

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Mouth Neoplasms


Psychiatry related information on Mouth Neoplasms


High impact information on Mouth Neoplasms


Chemical compound and disease context of Mouth Neoplasms


Biological context of Mouth Neoplasms


Anatomical context of Mouth Neoplasms

  • Using the cheek pouch of the Syrian hamster as an experimental model for oral carcinogenesis, it has recently been shown that eosinophils at sites of developing oral cancer express the multifunctional cytokine, transforming growth factor alpha (TGF-alpha) [21].
  • We found that high expression level of c-erbB-2 was frequently detected in oral cancer cell lines but not in the other head and neck SCC cell lines [22].
  • Beta-carotene was estimated in exfoliated oral mucosa cells in groups of individuals at various risks for oral cancer [23].
  • An elevated and statistically significant odds ratio (OR) was found for COPD deaths (OR = 2.53; 95% CI = 1.06-6.02), while nonsignificant increased ORs were present for oral cancers, cancers of the pharynx and larynx and leukemia [24].
  • Such changes were observed in clinically normal epithelium from oral cancer patients, involving primarily substantial expression of keratins K8/K7 (using CAM 5.2) in the basal cells of 12 out of 34 biopsies, and also a trend towards a reduction in the complexity of keratin differentiation [25].

Gene context of Mouth Neoplasms


Analytical, diagnostic and therapeutic context of Mouth Neoplasms


  1. Tolonium (toluidine blue) rinse--a screening method for recognition of squamous carcinoma. Continuing study of oral cancer IV. Mashberg, A. JAMA (1981) [Pubmed]
  2. Inappropriate retinoic acid receptor-beta expression in oral dysplasias: correlation with acquisition of the immortal phenotype. McGregor, F., Wagner, E., Felix, D., Soutar, D., Parkinson, K., Harrison, P.R. Cancer Res. (1997) [Pubmed]
  3. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Marsit, C.J., Liu, M., Nelson, H.H., Posner, M., Suzuki, M., Kelsey, K.T. Oncogene (2004) [Pubmed]
  4. NSAIDs for the chemoprevention of oral cancer: promise or pessimism?: Commentary re J. L. Mulshine et al., randomized, double-blind, placebo-controlled, phase IIB trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin. Cancer Res., 10: 1565-1573, 2004. Goodin, S., Shiff, S.J. Clin. Cancer Res. (2004) [Pubmed]
  5. Anticancer effect of a lentiviral vector capable of expressing HIV-1 Vpr. Pang, S., Kang, M.K., Kung, S., Yu, D., Lee, A., Poon, B., Chen, I.S., Lindemann, B., Park, N.H. Clin. Cancer Res. (2001) [Pubmed]
  6. Oral health services in primary care nursing centers: opportunities for dental hygiene and nursing collaboration. Fellona, M.O., DeVore, L.R. Journal of dental hygiene : JDH / American Dental Hygienists' Association. (1999) [Pubmed]
  7. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. Harty, L.C., Caporaso, N.E., Hayes, R.B., Winn, D.M., Bravo-Otero, E., Blot, W.J., Kleinman, D.V., Brown, L.M., Armenian, H.K., Fraumeni, J.F., Shields, P.G. J. Natl. Cancer Inst. (1997) [Pubmed]
  8. Effect of the synthetic retinoid fenretinide on dark adaptation and the ocular surface. Decensi, A., Torrisi, R., Polizzi, A., Gesi, R., Brezzo, V., Rolando, M., Rondanina, G., Orengo, M.A., Formelli, F., Costa, A. J. Natl. Cancer Inst. (1994) [Pubmed]
  9. Regression by vitamin E of experimental oral cancer. Shklar, G., Schwartz, J., Trickler, D.P., Niukian, K. J. Natl. Cancer Inst. (1987) [Pubmed]
  10. Reduction with vitamin A and beta-carotene administration of proportion of micronucleated buccal mucosal cells in Asian betal nut and tobacco chewers. Stich, H.F., Rosin, M.P., Vallejera, M.O. Lancet (1984) [Pubmed]
  11. Betel nuts, arecaidine, and oral cancer. Ashby, J., Styles, J.A., Boyland, E. Lancet (1979) [Pubmed]
  12. Bombesin antagonist prevents CO2 laser-induced promotion of oral cancer. Kozacko, M.F., Mang, T.S., Schally, A.V., Priore, R.L., Liebow, C. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  13. Serum micronutrients and the subsequent risk of oral and pharyngeal cancer. Zheng, W., Blot, W.J., Diamond, E.L., Norkus, E.P., Spate, V., Morris, J.S., Comstock, G.W. Cancer Res. (1993) [Pubmed]
  14. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. Mueller, A., Schäfer, B.W., Ferrari, S., Weibel, M., Makek, M., Höchli, M., Heizmann, C.W. J. Biol. Chem. (2005) [Pubmed]
  15. Potential role of beta-carotene in prevention of oral cancer. Garewal, H.S. Am. J. Clin. Nutr. (1991) [Pubmed]
  16. Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer. Tegeder, I., Bräutigam, L., Seegel, M., Al-Dam, A., Turowski, B., Geisslinger, G., Kovács, A.F. Clin. Pharmacol. Ther. (2003) [Pubmed]
  17. Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. Todd, R., McBride, J., Tsuji, T., Donoff, R.B., Nagai, M., Chou, M.Y., Chiang, T., Wong, D.T. FASEB J. (1995) [Pubmed]
  18. Cyclin G2 dysregulation in human oral cancer. Kim, Y., Shintani, S., Kohno, Y., Zhang, R., Wong, D.T. Cancer Res. (2004) [Pubmed]
  19. Insulin-like growth factor II receptor gene-167 genotype increases the risk of oral squamous cell carcinoma in humans. Zavras, A.I., Pitiphat, W., Wu, T., Cartsos, V., Lam, A., Douglass, C.W., Diehl, S.R. Cancer Res. (2003) [Pubmed]
  20. Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea. Thomas, S., Brennan, J., Martel, G., Frazer, I., Montesano, R., Sidransky, D., Hollstein, M. Cancer Res. (1994) [Pubmed]
  21. Eosinophils, tissue eosinophilia, and eosinophil-derived transforming growth factor alpha in hamster oral carcinogenesis. Ghiabi, M., Gallagher, G.T., Wong, D.T. Cancer Res. (1992) [Pubmed]
  22. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Xia, W., Lau, Y.K., Zhang, H.Z., Liu, A.R., Li, L., Kiyokawa, N., Clayman, G.L., Katz, R.L., Hung, M.C. Clin. Cancer Res. (1997) [Pubmed]
  23. Beta-carotene levels in exfoliated mucosa cells of population groups at low and elevated risk for oral cancer. Stich, H.F., Hornby, A.P., Dunn, B.P. Int. J. Cancer (1986) [Pubmed]
  24. Amount of DNA in plasma and cancer risk: a prospective study. Gormally, E., Hainaut, P., Caboux, E., Airoldi, L., Autrup, H., Malaveille, C., Dunning, A., Garte, S., Matullo, G., Overvad, K., Tjonneland, A., Clavel-Chapelon, F., Boffetta, P., Boeing, H., Trichopoulou, A., Palli, D., Krogh, V., Tumino, R., Panico, S., Bueno-de-Mesquita, H.B., Peeters, P.H., Lund, E., Gonzalez, C.A., Martinez, C., Dorronsoro, M., Barricarte, A., Tormo, M.J., Quiros, J.R., Berglund, G., Hallmans, G., Day, N.E., Key, T.J., Veglia, F., Peluso, M., Norat, T., Saracci, R., Kaaks, R., Riboli, E., Vineis, P. Int. J. Cancer (2004) [Pubmed]
  25. Evidence for field change in oral cancer based on cytokeratin expression. Ogden, G.R., Lane, E.B., Hopwood, D.V., Chisholm, D.M. Br. J. Cancer (1993) [Pubmed]
  26. Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib. Li, N., Sood, S., Wang, S., Fang, M., Wang, P., Sun, Z., Yang, C.S., Chen, X. Clin. Cancer Res. (2005) [Pubmed]
  27. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Arora, S., Kaur, J., Sharma, C., Mathur, M., Bahadur, S., Shukla, N.K., Deo, S.V., Ralhan, R. Clin. Cancer Res. (2005) [Pubmed]
  28. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer. Ralhan, R., Agarwal, S., Mathur, M., Wasylyk, B., Srivastava, A. Clin. Cancer Res. (2000) [Pubmed]
  29. Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Buch, S.C., Notani, P.N., Bhisey, R.A. Carcinogenesis (2002) [Pubmed]
  30. TGF-alpha and EGF-receptor mRNAs in human oral cancers. Todd, R., Donoff, B.R., Gertz, R., Chang, A.L., Chow, P., Matossian, K., McBride, J., Chiang, T., Gallagher, G.T., Wong, D.T. Carcinogenesis (1989) [Pubmed]
  31. DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. Saintigny, P., El-Naggar, A.K., Papadimitrakopoulou, V., Ren, H., Fan, Y.H., Feng, L., Lee, J.J., Kim, E.S., Hong, W.K., Lippman, S.M., Mao, L. Clin. Cancer Res. (2009) [Pubmed]
  32. Reduction of p12DOC-1 expression is a negative prognostic indicator in patients with surgically resected oral squamous cell carcinoma. Shintani, S., Mihara, M., Terakado, N., Nakahara, Y., Matsumura, T., Kohno, Y., Ohyama, H., McBride, J., Kent, R., Todd, R., Tsuji, T., Wong, D.T. Clin. Cancer Res. (2001) [Pubmed]
  33. Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells. Liu, R., Oberley, T.D., Oberley, L.W. Hum. Gene Ther. (1997) [Pubmed]
  34. Folate intake, serum homocysteine and methylenetetrahydrofolate reductase (MTHFR) C677T genotype are not associated with oral cancer risk in Puerto Rico. Weinstein, S.J., Gridley, G., Harty, L.C., Diehl, S.R., Brown, L.M., Winn, D.M., Bravo-Otero, E., Hayes, R.B. J. Nutr. (2002) [Pubmed]
  35. Expression of p53, PCNA, Ki-67 and bcl-2 in relation to risk factors in oral cancer - a molecular epidemiological study. Schildt, E.B., Nylander, K., Eriksson, M., Hardell, L., Magnusson, A., Roos, G. Int. J. Oncol. (2003) [Pubmed]
  36. Current laser dentistry. Goldman, L., Goldman, B., Van Lieu, N. Lasers in surgery and medicine. (1987) [Pubmed]
WikiGenes - Universities